Protein Expression Market: Growth, Size, Share, and Trends

Report Code BT 2435
Published in Nov, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Protein Expression Market by Product (Reagents, Vectors, Competent Cells, Instruments, Software), Services, System Type (Mammalian (CHO, HEK293), Insect, Yeast), Workflow, Application (Therapeutic, Research, Industrial) - Global Forecast to 2029

Market Growth Outlook Summary

The global protein expression market growth forecasted to transform from USD 3.41 billion in 2024 to USD 4.82 billion by 2029, driven by a CAGR of 7.1%. The increasing demand for biologics such as monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs), and vaccines, along with rising R&D investments in the pharmaceutical and biopharmaceutical industries, and the growing use of artificial intelligence and machine learning to enhance protein-based studies, are key factors driving market growth. Additionally, the development of personalized/precision medicines has accelerated in recent years, while the growing trend of outsourcing clinical research further supports market expansion. Moreover, the increasing focus on adopting plant-based and cell-free expression systems, along with advancements in synthetic protein production technologies, presents significant opportunities. Major players in this market are also expanding their geographic presence by establishing manufacturing and research facilities in emerging economies.

Protein Expression Market – Global Forecast and Key Opportunities to 2029

Asia Pacific

The growth of the North American protein expression market is primarily due to the presence of major protein expression offering suppliers and consumers in the region, supported by increasing funding and investments in the development of protein-based therapies.

Growth in this market is primarily driven by the increasing demand for biologics supported by the rise in R&D within the pharmaceutical & biopharmaceutical industries and the growing use of artificial intelligence and machine learning to enhance the protein expression workflow.

The growing emphasis on the development of plant-based and cell-free expression systems for sustainable and cost-effective protein expression and the advancement in synthetic protein production technologies are likely to offer potential growth opportunities in the market.

The rise in the protein expression market in the Asia Pacific region is supported by the growing trend of outsourcing various clinical activities, such as drug research and development.

Factors such as the high cost of protein expression offerings and the renewed focus on small molecules in drug development pose a challenge to the growth of this market.

Protein Expression Market Dynamics to 2029

DRIVER: Increasing demand for biologics

The increasing development of protein therapeutics, such as monoclonal antibodies and antibody-drug conjugates, is a key factor in the expansion of the protein expression market. Biologics are often utilized to treat cancer, autoimmune diseases, and chronic inflammatory diseases. Regulatory authorities worldwide have been approving biologics for commercial use, supporting the growth in the protein expression market. 17 new biologics received approval from the US FDA in 2023, 12 of which were monoclonal antibodies. There has been a growing demand for high-performance protein expression systems to support the large-scale manufacturing of these therapeutic products. Moreover, the rise in the Biologics License Application (BLA) approvals supports a growing biologics market, further enhancing the adoption of advanced protein expression systems. Unmet therapeutic needs for various diseases are supporting novel treatment development, thus supporting the protein expression market.

RESTRAINT: Renewed focus on small molecules in drug development

The pharmaceutical industry has focused its attention on the research and development of small molecule-based drugs, which are slowing the growth of biologics and affecting the development of the protein expression market. Small molecules are preferred as they are more affordable, easier to administer, and have broader applications in therapies. In 2023, the US FDA approved 55 new drugs, of which over half were small molecules. This highlighted a strong focus by the industry on these drug modalities. Such a strong preference toward the research on small-molecule drugs can limit R&D investments in biologics, limiting the growth in the protein expression market.

 

OPPORTUNITY: Growing emphasis on plant-based and cell-free expression systems

The protein expression market presents various growth opportunities for companies operating in this market owing to the growing focus on developing and using plant-based and cell-free expression systems as an alternative to traditional mammalian and bacterial protein expression systems. Though traditional protein expression systems have constituted much of the biomanufacturing of many recombinant therapeutic and industrial proteins, they also pose several challenges in terms of their scalability and protein folding. The adoption of plant-based and cell-free protein expression (CFPE) methods is increasing due to their higher efficiencies and scalability at lower costs. Plant-based systems are easier to scale by increasing plant cultivation, leading to lower infrastructure costs and a faster production timeline. These systems consume less energy, recycle water, and produce less waste, and thus, are environmentally sustainable. Cell-free expression methods produce proteins outside living cells and improve flexibility and yield, especially for complex proteins requiring post-translational modifications. Platforms such as Alice by LenioBio GmbH (Germany) have demonstrated the ability of cell-free expression systems to produce proteins at large scales with high precision.

CHALLENGES: Production cost and efficiency issues

A major challenge in the protein expression market is the high production cost and efficiency issues associated with various protein expression systems designed for production. Bacterial systems, while inexpensive and high-yielding, typically produce inclusion bodies and insoluble aggregates of proteins that complicate purification and reduce yield. These systems lack the machinery for post-translational modifications required for proper protein function. Yeast systems can perform partial modification of the protein products. The high production costs and challenges in maintaining desired conditions for amplification are major hurdles faced while using these systems. The mammalian systems are more suitable for complex proteins but incur higher production and labor costs. These systems relatively exhibit lower expression levels than those in both bacterial and yeast systems. Additionally, plant-based systems have problems regarding the spread of recombinant genes and proteins into the food chain, limiting their adoption. These system-specific problems, combined with difficulties in low-cost commercial scalability and downstream processing, challenge large-scale protein manufacturing.

Protein Expression Market Map & Ecosystem Overview

The ecosystem for protein expression offerings comprises major life science companies offering protein expression products and services, regulatory authorities, and end users, such as academic & research institutes, CROs & CDMOs, pharmaceutical & biotechnology companies, and other end users. These stakeholders interact and collaborate to drive the advancement of protein expression solutions.

 

The extraction, purification, and characterization segment held the largest market share in the protein expression market, by workflow, in 2023.

Based on the workflow, the protein expression market is segmented into three phases, namely, cloning & transfection, transcription, translation, & post-translational modification (PTM), and extraction, purification, and characterization. The extraction, purification, & characterization segment held the largest market share of the protein expression market by workflow in 2023. This is the final stage of the protein expression workflow and involves steps such as isolation, purification, and verification of the properties of the expressed proteins. This phase involves the use of various extraction and purification instruments and specialized reagents that are generally expensive, leading to a large share of this segment.

The pharmaceutical & biotechnology companies led the protein expression products market, by end user in 2023.

Based on various end users utilizing protein expression products, the market is segmented into pharmaceuticals & biotechnology companies, academic research institutes, CROS & CDMOs, and other end users. In 2023, the pharmaceutical & biotechnology companies segment accounted for the largest share of the protein expression products market by end user. This large share is supported by the rising approval and use of therapeutic protein-based drugs, like monoclonal antibodies and vaccines. This has increased the need for efficient protein expression products from pharmaceutical and biotech companies, driving market growth. Additionally, the rising prevalence of chronic diseases worldwide has led to an increase in R&D investments for developing new therapies, further increasing demand for protein expression products.

North America was the dominant region in the protein expression market in 2023.

The North American protein expression market emerged as the largest protein expression market in 2023, which is expected to remain the same during the forecast period. The large share of this regional market is supported by the presence of major pharmaceutical and biotechnology companies actively focusing on developing novel protein-based therapies. The presence of prominent academic and research institutions has also supported the large share of this market. Moreover, the rising prevalence of chronic disorders, such as cancer and autoimmune diseases, and increased investments and funding in protein-based therapeutics research in the region further boost the market of protein expression offerings in the region.

HIGHEST CAGR MARKET IN 2024-2029
US FASTEST GROWING MARKET IN THE REGION

Protein Expression Market Recent Developments and Insights

  • In June 2024, Thermo Fisher Scientific, Inc. (US) launched the Thermo Scientific Stellar mass spectrometer (MS), offering high throughput operations supporting translational omics research.
  • In July 2024, Thermo Fisher Scientific, Inc. (US) acquired Olink Holding AB (Sweden) to enhance its mass spectrometry and life science offerings.
  • In August 2024, Merck KGaA (Germany) acquired Mirus Bio (US) to improve its viral vector manufacturing capabilities and strengthen its bioprocessing portfolio by integrating the latter’s advanced transfection reagents.
  • In July 2024, Merck KGaA (Germany) launched its first GMP-compliant cell culture media (CCM) manufacturing facility in its life science center in Nantong, China.

Protein Expression Market – Leading Key Players Analysis

Want to explore hidden markets that can drive new revenue in Protein Expression Market?

Scope of the Report

Report Metric Details
Market Size (2024-2029) USD 3.41 billion in 2024 to USD 4.82 billion in 2029, at a CAGR of 7.1%
Growth Drivers Increasing demand for biologics like monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs), and vaccines, along with the rise of AI and ML in enhancing protein-based studies.
Key Opportunity Growing focus on plant-based and cell-free expression systems, offering sustainable and cost-effective protein production.
Restraints Focus on small molecules in drug development, shifting attention away from biologics, limiting market growth potential.
Challenges High production costs and efficiency issues with protein expression systems, including scalability challenges and post-translational modifications.
Leading Technology Advancements in AI/ML for protein structure prediction and optimization of expression systems, including plant-based and cell-free methods.
Market Segmentation Overview - By Workflow: Cloning & transfection, Transcription, Translation & PTM, Extraction & purification.
- By Expression System: Mammalian, Bacterial, Yeast, Plant-based, Cell-free.
- By End-User: Pharmaceutical & Biotech companies, Academic & Research institutes, CROs & CDMOs.
- By Application: Therapeutic proteins, Vaccines, Diagnostics.
Regional Market Insights - North America: Largest market share, driven by R&D activities and biotech focus.
- Europe: Increasing focus on protein therapeutics and biotech investments.
- Asia-Pacific: Emerging markets, growing adoption of advanced protein expression systems.

Key Questions Addressed by the Report

The protein expression market is projected to grow from USD 3.41 billion in 2024 to USD 4.82 billion by 2029, demonstrating a robust CAGR of 7.1%.
Drivers include increased R&D in pharmaceuticals and biopharmaceuticals, the growing demand for biologics, advancements in AI and machine learning, and the rise of synthetic protein production technologies.
Mammalian cell expression systems, particularly Chinese hamster ovary (CHO) cells, are the most commonly used due to their ability to produce complex proteins like monoclonal antibodies (mAbs) and vaccines.
The therapeutic application segment dominates, driven by the increasing demand for therapeutic proteins and the rise in chronic diseases requiring protein-based therapies like mAbs and vaccines.
Key opportunities include advancements in recombinant protein production, the growing adoption of cell-free expression systems, and the increasing application of AI for protein optimization and synthesis in various industries such as agriculture and cosmetics.
Leading companies include Thermo Fisher Scientific, Merck KGaA, Danaher Corporation, Sartorius AG, Agilent Technologies, and Bio-Rad Laboratories, all of which provide innovative products and services in protein expression technologies.
Challenges include high production costs of protein expression systems, dominance of small molecules in drug development, and the complex regulatory requirements surrounding protein-based therapies and biologics.

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Protein Expression Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
44
RESEARCH METHODOLOGY
49
EXECUTIVE SUMMARY
61
PREMIUM INSIGHTS
66
MARKET OVERVIEW
70
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Increasing demand for biologics
    - Rise in R&D in pharmaceutical and biopharmaceutical industries
    - Growing use of artificial intelligence and machine learning
    - Increasing shift toward personalized medicines
    - Growing outsourcing of clinical activities
    RESTRAINTS
    - High cost of protein expression offerings
    - Renewed focus on small molecules in drug development
    OPPORTUNITIES
    - Growing emphasis on plant-based and cell-free expression systems
    - Booming market in emerging economies
    - Increasing development of synthetic protein production technologies
    - Growing use of recombinant proteins
    CHALLENGES
    - Production cost and efficiency issues
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.4 PRICING ANALYSIS
    AVERAGE SELLING PRICE TREND OF PROTEIN EXPRESSION PRODUCTS
    AVERAGE SELLING PRICE, BY KEY PLAYER
    - Average selling price of system types, by key player
    - Average selling price trend of protein expression instruments, by key player
    AVERAGE SELLING PRICE, BY REGION
    - Average selling price of protein expression consumable products, by region
    - Average selling price trend of protein expression instruments, by region
  • 5.5 SUPPLY CHAIN ANALYSIS
  • 5.6 VALUE CHAIN ANALYSIS
  • 5.7 ECOSYSTEM ANALYSIS
  • 5.8 INVESTMENT/FUNDING ACTIVITY
  • 5.9 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Recombinant DNA technology
    - Transfection technologies
    - Protein expression systems
    ADJACENT TECHNOLOGIES
    - Extraction technologies
    - Purification and characterization technologies
    COMPLEMENTARY TECHNOLOGIES
    - High-throughput technologies
    - Computation protein designing
  • 5.10 PATENT ANALYSIS
  • 5.11 TRADE ANALYSIS
    IMPORT DATA
    EXPORT DATA
  • 5.12 KEY CONFERENCES AND EVENTS, 2024–2025
  • 5.13 REGULATORY ANALYSIS
    REGULATORY LANDSCAPE
    - North America
    - Europe
    - Emerging economies
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.14 PORTER’S FIVE FORCES ANALYSIS
    INTENSITY OF COMPETITIVE RIVALRY
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
  • 5.15 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
    - Buying criteria for protein expression products
    - Buying criteria for protein expression services
  • 5.16 IMPACT OF AI/GEN AI ON PROTEIN EXPRESSION MARKET
    INTRODUCTION
    MARKET POTENTIAL FOR PROTEIN EXPRESSION APPLICATIONS
    AI USE CASES
    KEY COMPANIES IMPLEMENTING AI
    FUTURE OF GENERATIVE AI IN PROTEIN EXPRESSION ECOSYSTEM
PROTEIN EXPRESSION MARKET, BY OFFERING
124
  • 6.1 INTRODUCTION
  • 6.2 PRODUCTS
    REAGENTS & KITS
    - Increasing use for cloning, transfection, purification, and characterization to spur growth
    EXPRESSION VECTORS
    - Growing production of complex proteins to propel market
    COMPETENT CELLS
    - Increasing demand for therapeutic proteins to expedite growth
    INSTRUMENTS & SOFTWARE
    - Increasing demand for biopharmaceuticals and personalized therapies to augment growth
  • 6.3 SERVICES
    GROWING UTILIZATION OF PROTEIN EXPRESSION SERVICES FOR LARGE-SCALE PRODUCTION TO FUEL MARKET
PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE
141
  • 7.1 INTRODUCTION
  • 7.2 MAMMALIAN CELL EXPRESSION SYSTEMS
    CHINESE HAMSTER OVARY (CHO) CELL SYSTEMS
    - High viability, rapid growth, and improved expression levels to support growth
    HUMAN EMBRYONIC KIDNEY (HEK 293) CELL SYSTEMS
    - Wide usage in transient transfection studies to augment growth
    OTHER MAMMALIAN CELL SYSTEMS
  • 7.3 PROKARYOTIC EXPRESSION SYSTEMS
    ESCHERICHIA COLI SYSTEMS
    - High cell density and low cost of media to stimulate growth
    OTHER PROKARYOTIC EXPRESSION SYSTEMS
  • 7.4 INSECT CELL EXPRESSION SYSTEMS
    BACULOVIRUS SYSTEMS
    - Increasing production of biologically active and functional recombinant proteins to speed up growth
    OTHER INSECT CELL EXPRESSION SYSTEMS
  • 7.5 YEAST EXPRESSION SYSTEMS
    PICHIA SYSTEMS
    - Rising production of antibody fragments, and vaccines to fuel growth
    SACCHAROMYCES SYSTEMS
    - Increasing use of saccharomyces systems for producing heterologous proteins to accelerate growth
    OTHER YEAST EXPRESSION SYSTEMS
  • 7.6 CELL-FREE EXPRESSION SYSTEMS
    INCREASING DEMAND FOR RECOMBINANT PROTEINS TO SUPPORT MARKET
  • 7.7 ALGAL-BASED EXPRESSION SYSTEMS
    GROWING USE OF ALGAL-BASED EXPRESSION SYSTEMS IN ANTIBODY AND VACCINE GENERATION TO BOOST MARKET
PROTEIN EXPRESSION MARKET, BY WORKFLOW
186
  • 8.1 INTRODUCTION
  • 8.2 CLONING & TRANSFECTION
    CONTINUOUS REPLENISHMENT OF CONSUMABLES AND REAGENTS TO SUPPORT MARKET
  • 8.3 TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION (PTM)
    GROWING NEED FOR FUNCTIONAL AND STABLE PROTEINS TO DRIVE MARKET
  • 8.4 EXTRACTION, PURIFICATION, AND CHARACTERIZATION
    NEED TO ADHERE TO REQUIRED STANDARDS FOR SUITABLE APPLICATIONS TO DRIVE MARKET
PROTEIN EXPRESSION MARKET, BY APPLICATION
195
  • 9.1 INTRODUCTION
  • 9.2 THERAPEUTIC APPLICATIONS
    RISING DEMAND FOR BIOLOGICS THERAPIES TO FACILITATE GROWTH
  • 9.3 RESEARCH APPLICATIONS
    GROWING INTEREST IN PROTEOMICS, GENOMICS, AND DRUG DISCOVERY TO BOOST MARKET
  • 9.4 INDUSTRIAL APPLICATIONS
    INCREASING USE OF PROTEINS IN COSMETICS, TEXTILES, AND INDUSTRIAL ENZYMES TO PROMOTE GROWTH
PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER
206
  • 10.1 INTRODUCTION
  • 10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    INCREASING APPROVALS FOR BIOLOGICS TO STIMULATE GROWTH
  • 10.3 ACADEMIC & RESEARCH INSTITUTES
    RISE IN GOVERNMENT AND PRIVATE FUNDING TO CONTRIBUTE TO MARKET GROWTH
  • 10.4 CONTRACT RESEARCH ORGANIZATIONS & CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS (CROS & CDMOS)
    INCREASING OUTSOURCING AND COLLABORATIONS FOR PHARMACEUTICAL MANUFACTURING AND CLINICAL TRIALS TO SUSTAIN MARKET
  • 10.5 OTHER END USERS
PROTEIN EXPRESSION SERVICES MARKET, BY END USER
220
  • 11.1 INTRODUCTION
  • 11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    INCREASING SHIFT TOWARD DRUG DEVELOPMENT OUTSOURCING TO FAVOR GROWTH
  • 11.3 ACADEMIC & RESEARCH INSTITUTES
    RISING PARTNERSHIPS BETWEEN ACADEMIA AND CONTRACT RESEARCH ORGANIZATIONS TO AID GROWTH
  • 11.4 OTHER END USERS
PROTEIN EXPRESSION MARKET, BY REGION
230
  • 12.1 INTRODUCTION
  • 12.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    US
    - Growing focus on developing new therapeutics and protein-based drugs to drive market
    CANADA
    - Increasing incidence of cancer and prevalence of public-private partnerships to sustain growth
  • 12.3 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    - Increasing proteomics-based research and healthcare investments to promote growth
    UK
    - Growing development of immunotherapies, vaccines, and proteomics to fuel market
    FRANCE
    - Rise in funding for proteomics and genomics to spur growth
    ITALY
    - Growing life science research supported by universities and research institutions to boost market
    SPAIN
    - Increasing international collaborations for drug development to fuel market
    NETHERLANDS
    - Presence of advanced infrastructure to fuel market
    REST OF EUROPE
  • 12.4 ASIA PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    CHINA
    - Extensive government funding in genomics and protein research to boost market
    JAPAN
    - Increasing initiatives by government associations in life sciences sector to support market growth
    INDIA
    - Rising collaborations between private sector and academia to facilitate growth
    AUSTRALIA
    - Growing focus on developing new proteins and peptides to drive market
    SOUTH KOREA
    - Increasing research & development of novel therapies to facilitate growth
    REST OF ASIA PACIFIC
  • 12.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    BRAZIL
    - Growing industrial investments to propel market
    MEXICO
    - Increase in chronic diseases and robust research ecosystem to expedite growth
    ARGENTINA
    - Rise in biotechnology and pharmaceutical research & development to augment growth
    REST OF LATIN AMERICA
  • 12.6 MIDDLE EAST
    MACROECONOMIC OUTLOOK FOR MIDDLE EAST
    GCC COUNTRIES
    - Strategic investments between government authorities and private players to drive market
    REST OF MIDDLE EAST
  • 12.7 AFRICA
    FAVORABLE INSURANCE PROGRAMS AND CLINICAL TRIALS TO CONTRIBUTE TO MARKET GROWTH
    MACROECONOMIC OUTLOOK FOR AFRICA
COMPETITIVE LANDSCAPE
356
  • 13.1 OVERVIEW
  • 13.2 KEY PLAYER STRATEGY/RIGHT TO WIN, 2021–2024
  • 13.3 REVENUE ANALYSIS, 2021–2023
  • 13.4 MARKET SHARE ANALYSIS, 2023
  • 13.5 COMPANY EVALUATION QUADRANT: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Company footprint
    - Region footprint
    - Offering footprint
    - Expression system footprint
    - Application footprint
  • 13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    - Detailed list of key startups/SMES
    - Competitive benchmarking of startups/SMEs
  • 13.7 COMPANY VALUATION AND FINANCIAL METRICS
    COMPANY VALUATION
    FINANCIAL METRICS
  • 13.8 BRAND/PRODUCT COMPARISON
  • 13.9 COMPETITIVE SCENARIO
    PRODUCT/SERVICE LAUNCHES
    DEALS
    EXPANSIONS
COMPANY PROFILES
382
  • 14.1 KEY PLAYERS
    THERMO FISHER SCIENTIFIC INC.
    - Business overview
    - Products and services offered
    - Recent developments
    - MnM view
    MERCK KGAA
    - Business overview
    - Products and services offered
    - Recent developments
    - MnM view
    DANAHER CORPORATION
    - Business overview
    - Products and services offered
    - Recent developments
    - MnM view
    AGILENT TECHNOLOGIES, INC.
    - Business overview
    - Products and services offered
    - MnM view
    SARTORIUS AG
    - Business overview
    - Products and services offered
    - Recent developments
    - MnM view
    GENSCRIPT
    - Business overview
    - Products and services offered
    - Recent developments
    - MnM view
    TAKARA BIO INC.
    - Business overview
    - Products and services offered
    BIO-RAD LABORATORIES, INC.
    - Business overview
    - Products and services offered
    QIAGEN
    - Business overview
    - Products and services offered
    CHARLES RIVER LABORATORIES
    - Business overview
    - Products and services offered
    CORNING INCORPORATED
    - Business overview
    - Products and services offered
    LONZA
    - Business overview
    - Products and services offered
    - Recent developments
    FUJIFILM IRVINE SCIENTIFIC, INC.
    - Business overview
    - Products and services offered
    - Recent developments
    SYNGENE INTERNATIONAL LIMITED
    - Business overview
    - Products and services offered
    - Recent developments
    LGC LIMITED
    - Business overview
    - Products and services offered
    EUROFINS SCIENTIFIC
    - Business overview
    - Products and services offered
    AJINOMOTO CO., INC.
    - Business overview
    - Products and services offered
  • 14.2 OTHER PLAYERS
    PROMEGA CORPORATION
    SINO BIOLOGICAL, INC.
    RAYBIOTECH, INC.
    BIONEER CORPORATION
    ORIGENE TECHNOLOGIES, INC.
    NEW ENGLAND BIOLABS
    ACCURUS BIOSCIENCES
    ARAGEN LIFE SCIENCES LTD.
    OXFORD EXPRESSION TECHNOLOGIES LTD
    PROTEOGENIX INC.
    ABEOMICS
APPENDIX
463
  • 15.1 DISCUSSION GUIDE
  • 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 15.3 CUSTOMIZATION OPTIONS
  • 15.4 RELATED REPORTS
  • 15.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 PROTEIN EXPRESSION MARKET: INCLUSIONS AND EXCLUSIONS
  • TABLE 2 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
  • TABLE 3 PROTEIN EXPRESSION MARKET: RISK ASSESSMENT
  • TABLE 4 PROTEIN EXPRESSION MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
  • TABLE 5 BIOLOGICS AND CELL LINES FOR PRODUCTION
  • TABLE 6 PROTEINS SYNTHESIZED BY PROTEIN EXPRESSION AND GENETIC ENGINEERING
  • TABLE 7 AVERAGE SELLING PRICE TREND OF PROTEIN EXPRESSION PRODUCTS, 2021–2023 (USD)
  • TABLE 8 AVERAGE SELLING PRICE OF SYSTEM TYPES, BY KEY PLAYER, 2023 (USD)
  • TABLE 9 AVERAGE SELLING PRICE TREND OF PROTEIN EXPRESSION INSTRUMENTS, BY KEY PLAYER, 2021–2023 (USD)
  • TABLE 10 AVERAGE SELLING PRICE OF PROTEIN EXPRESSION CONSUMABLE PRODUCTS, BY REGION, 2023 (USD)
  • TABLE 11 AVERAGE SELLING PRICE TREND OF PROTEIN EXPRESSION INSTRUMENTS, BY REGION, 2021–2023 (USD)
  • TABLE 12 PROTEIN EXPRESSION MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 13 PATENTS FILED, BY DOCUMENT TYPE, 2014–2024
  • TABLE 14 PROTEIN EXPRESSION MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2022–2024
  • TABLE 15 IMPORT DATA FOR MASS SPECTROMETERS HS CODE (902781), 2022–2023, (USD THOUSAND)
  • TABLE 16 IMPORT DATA FOR MASS SPECTROMETERS HS CODE (902781), 2022–2023, (UNIT)
  • TABLE 17 EXPORT DATA FOR MASS SPECTROMETERS HS CODE (902781), 2022–2023, (USD THOUSAND)
  • TABLE 18 EXPORT DATA FOR MASS SPECTROMETERS HS CODE (902781), 2022–2023, (UNIT)
  • TABLE 19 PROTEIN EXPRESSION MARKET: KEY CONFERENCES AND EVENTS, 2024–2025
  • TABLE 20 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 21 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 22 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 23 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 24 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 25 PROTEIN EXPRESSION MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
  • TABLE 27 BUYING CRITERIA FOR PROTEIN EXPRESSION PRODUCTS, BY END USER
  • TABLE 28 BUYING CRITERIA FOR PROTEIN EXPRESSION SERVICES, BY END USER
  • TABLE 29 PROTEIN EXPRESSION MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 30 PROTEIN EXPRESSION PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 31 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 32 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 33 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 34 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 35 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 36 PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 37 PROTEIN EXPRESSION PRODUCTS MARKET FOR REAGENTS & KITS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 38 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR REAGENTS & KITS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 39 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR REAGENTS & KITS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 40 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR REAGENTS & KITS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 41 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR REAGENTS & KITS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 42 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR REAGENTS & KITS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 43 PROTEIN EXPRESSION PRODUCTS MARKET FOR EXPRESSION VECTORS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 44 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR EXPRESSION VECTORS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 45 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR EXPRESSION VECTORS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 46 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR EXPRESSION VECTORS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 47 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR EXPRESSION VECTORS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 48 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR EXPRESSION VECTORS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 49 PROTEIN EXPRESSION PRODUCTS MARKET FOR COMPETENT CELLS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 50 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR COMPETENT CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 51 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR COMPETENT CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 52 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR COMPETENT CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 53 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR COMPETENT CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 54 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR COMPETENT CELLS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 55 PROTEIN EXPRESSION PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 56 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR INSTRUMENTS AND SOFTWARE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 57 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 58 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 59 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 60 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR INSTRUMENTS & SOFTWARE, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 61 PROTEIN EXPRESSION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 62 NORTH AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 63 EUROPE: PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 64 ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 65 LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 66 MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 67 PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022–2029 (USD MILLION)
  • TABLE 68 PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 69 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 70 EUROPE: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 71 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 72 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 73 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 74 PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 75 PROTEIN EXPRESSION MARKET FOR CHINESE HAMSTER OVARY CELL SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 76 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR CHINESE HAMSTER OVARY CELL SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 77 EUROPE: PROTEIN EXPRESSION MARKET FOR CHINESE HAMSTER OVARY CELL SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 78 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR CHINESE HAMSTER OVARY CELL SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 79 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR CHINESE HAMSTER OVARY CELL SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 80 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR CHINESE HAMSTER OVARY CELL SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 81 PROTEIN EXPRESSION MARKET FOR HUMAN EMBRYONIC KIDNEY CELL SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 82 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR HUMAN EMBRYONIC KIDNEY CELL SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 83 EUROPE: PROTEIN EXPRESSION MARKET FOR HUMAN EMBRYONIC KIDNEY CELL SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 84 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR HUMAN EMBRYONIC KIDNEY CELL SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 85 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR HUMAN EMBRYONIC KIDNEY CELL SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 86 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR HUMAN EMBRYONIC KIDNEY CELL SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 87 PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 88 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 89 EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 90 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 91 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 92 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 93 PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 94 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 95 EUROPE: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 96 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 97 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 98 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 99 PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 100 PROTEIN EXPRESSION MARKET FOR ESCHERICHIA COLI SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 101 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR ESCHERICHIA COLI SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 102 EUROPE: PROTEIN EXPRESSION MARKET FOR ESCHERICHIA COLI SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 103 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR ESCHERICHIA COLI SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 104 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR ESCHERICHIA COLI SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 105 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR ESCHERICHIA COLI SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 106 PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 107 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 108 EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 109 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 110 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 111 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 112 PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 113 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 114 EUROPE: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 115 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 116 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 117 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 118 PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 119 PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 120 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 121 EUROPE: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 122 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 123 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 124 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 125 PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL EXPRESSION SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 126 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 127 EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 128 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 129 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 130 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL EXPRESSION SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 131 PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 132 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 133 EUROPE: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 134 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 135 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 136 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 137 PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 138 PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 139 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 140 EUROPE: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 141 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 142 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 143 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 144 PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 145 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 146 EUROPE: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 147 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 148 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 149 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 150 PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 151 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 152 EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 153 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 154 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 155 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 156 PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 157 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 158 EUROPE: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 159 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 160 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 161 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 162 PROTEIN EXPRESSION MARKET FOR ALGAL-BASED EXPRESSION SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 163 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR ALGAL-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 164 EUROPE: PROTEIN EXPRESSION MARKET FOR ALGAL-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 165 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR ALGAL-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 166 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR ALGAL-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 167 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR ALGAL-BASED EXPRESSION SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 168 PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 169 PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 170 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 171 EUROPE: PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 172 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 173 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 174 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR CLONING & TRANSFECTION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 175 PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 176 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 177 EUROPE: PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 178 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 179 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 180 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR TRANSCRIPTION, TRANSLATION, AND POST-TRANSLATIONAL MODIFICATION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 181 PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 182 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 183 EUROPE: PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 184 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 185 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 186 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR EXTRACTION, PURIFICATION, AND CHARACTERIZATION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 187 PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 188 PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 189 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 190 EUROPE: PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 191 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 192 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 193 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 194 PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 195 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 196 EUROPE: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 197 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 198 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 199 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 200 LIST OF INDUSTRIAL ENZYMES AND APPLICATIONS
  • TABLE 201 PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 202 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 203 EUROPE: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 204 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 205 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 206 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 207 PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 208 PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 209 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 210 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 211 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 212 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 213 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 214 PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 215 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 216 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 217 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 218 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 219 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 220 PROTEIN EXPRESSION PRODUCTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS & CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 221 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS & CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 222 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS & CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 223 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS & CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 224 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS & CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 225 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS & CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 226 PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 227 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 228 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 229 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 230 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 231 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 232 PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 233 PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 234 NORTH AMERICA: PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 235 EUROPE: PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 236 ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 237 LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 238 MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 239 PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 240 NORTH AMERICA: PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 241 EUROPE: PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 242 ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 243 LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 244 MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 245 PROTEIN EXPRESSION SERVICES MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 246 NORTH AMERICA: PROTEIN EXPRESSION SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 247 EUROPE: PROTEIN EXPRESSION SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 248 ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 249 LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 250 MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 251 PROTEIN EXPRESSION MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 252 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 253 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 254 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 255 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022–2029 (USD MILLION)
  • TABLE 256 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 257 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 258 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 259 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 260 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 261 NORTH AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 262 NORTH AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 263 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 264 NORTH AMERICA: KEY MACROECONOMIC INDICATORS
  • TABLE 265 US: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 266 US: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 267 US: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 268 US: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022–2029 (USD MILLION)
  • TABLE 269 US: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 270 US: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 271 US: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 272 US: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 273 US: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 274 US: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 275 US: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 276 CANADA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 277 CANADA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 278 CANADA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 279 CANADA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022–2029 (USD MILLION)
  • TABLE 280 CANADA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 281 CANADA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 282 CANADA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 283 CANADA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 284 CANADA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 285 CANADA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 286 CANADA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 287 EUROPE: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 288 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 289 EUROPE: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 290 EUROPE: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022–2029 (USD MILLION)
  • TABLE 291 EUROPE: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 292 EUROPE: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 293 EUROPE: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 294 EUROPE: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 295 EUROPE: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 296 EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 297 EUROPE: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 298 EUROPE: PROTEIN EXPRESSION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 299 EUROPE: KEY MACROECONOMIC INDICATORS
  • TABLE 300 GERMANY: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 301 GERMANY: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 302 GERMANY: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 303 GERMANY: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022–2029 (USD MILLION)
  • TABLE 304 GERMANY: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 305 GERMANY: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 306 GERMANY: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 307 GERMANY: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 308 GERMANY: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 309 GERMANY: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 310 GERMANY: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 311 UK: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 312 UK: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 313 UK: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 314 UK: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022–2029 (USD MILLION)
  • TABLE 315 UK: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 316 UK: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 317 UK: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 318 UK: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 319 UK: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 320 UK: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 321 UK: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 322 FRANCE: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 323 FRANCE: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 324 FRANCE: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 325 FRANCE: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022–2029 (USD MILLION)
  • TABLE 326 FRANCE: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 327 FRANCE: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 328 FRANCE: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 329 FRANCE: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 330 FRANCE: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 331 FRANCE: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 332 FRANCE: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 333 ITALY: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 334 ITALY: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 335 ITALY: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 336 ITALY: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022–2029 (USD MILLION)
  • TABLE 337 ITALY: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 338 ITALY: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 339 ITALY: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 340 ITALY: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 341 ITALY: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 342 ITALY: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 343 ITALY: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 344 SPAIN: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 345 SPAIN: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 346 SPAIN: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 347 SPAIN: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022–2029 (USD MILLION)
  • TABLE 348 SPAIN: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 349 SPAIN: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 350 SPAIN: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 351 SPAIN: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 352 SPAIN: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 353 SPAIN: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 354 SPAIN: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 355 NETHERLANDS: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 356 NETHERLANDS: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 357 NETHERLANDS: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 358 NETHERLANDS: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022–2029 (USD MILLION)
  • TABLE 359 NETHERLANDS: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 360 NETHERLANDS: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 361 NETHERLANDS: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 362 NETHERLANDS: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 363 NETHERLANDS: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 364 NETHERLANDS: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 365 NETHERLANDS: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 366 REST OF EUROPE: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 367 REST OF EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 368 REST OF EUROPE: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 369 REST OF EUROPE: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022–2029 (USD MILLION)
  • TABLE 370 REST OF EUROPE: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 371 REST OF EUROPE: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 372 REST OF EUROPE: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 373 REST OF EUROPE: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 374 REST OF EUROPE: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 375 REST OF EUROPE: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 376 REST OF EUROPE: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 377 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 378 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 379 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 380 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022–2029 (USD MILLION)
  • TABLE 381 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 382 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 383 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 384 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 385 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 386 ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 387 ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 388 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 389 ASIA PACIFIC: KEY MACROECONOMIC INDICATORS
  • TABLE 390 CHINA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 391 CHINA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 392 CHINA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 393 CHINA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022–2029 (USD MILLION)
  • TABLE 394 CHINA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 395 CHINA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 396 CHINA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 397 CHINA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 398 CHINA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 399 CHINA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 400 CHINA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 401 JAPAN: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 402 JAPAN: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 403 JAPAN: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 404 JAPAN: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022–2029 (USD MILLION)
  • TABLE 405 JAPAN: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 406 JAPAN: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 407 JAPAN: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 408 JAPAN: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 409 JAPAN: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 410 JAPAN: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 411 JAPAN: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 412 INDIA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 413 INDIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 414 INDIA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 415 INDIA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022–2029 (USD MILLION)
  • TABLE 416 INDIA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 417 INDIA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 418 INDIA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 419 INDIA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 420 INDIA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 421 INDIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 422 INDIA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 423 AUSTRALIA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 424 AUSTRALIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 425 AUSTRALIA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 426 AUSTRALIA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022–2029 (USD MILLION)
  • TABLE 427 AUSTRALIA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 428 AUSTRALIA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 429 AUSTRALIA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 430 AUSTRALIA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 431 AUSTRALIA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 432 AUSTRALIA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 433 AUSTRALIA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 434 SOUTH KOREA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 435 SOUTH KOREA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 436 SOUTH KOREA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 437 SOUTH KOREA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022–2029 (USD MILLION)
  • TABLE 438 SOUTH KOREA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 439 SOUTH KOREA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 440 SOUTH KOREA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 441 SOUTH KOREA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 442 SOUTH KOREA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 443 SOUTH KOREA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 444 SOUTH KOREA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 445 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 446 REST OF ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 447 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 448 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022–2029 (USD MILLION)
  • TABLE 449 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 450 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 451 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 452 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 453 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 454 REST OF ASIA PACIFIC: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 455 REST OF ASIA PACIFIC: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 456 LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 457 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 458 LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 459 LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022–2029 (USD MILLION)
  • TABLE 460 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 461 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 462 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 463 LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 464 LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 465 LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 466 LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 467 LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 468 LATIN AMERICA: KEY MACROECONOMIC INDICATORS
  • TABLE 469 BRAZIL: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 470 BRAZIL: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 471 BRAZIL: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 472 BRAZIL: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022–2029 (USD MILLION)
  • TABLE 473 BRAZIL: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 474 BRAZIL: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 475 BRAZIL: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 476 BRAZIL: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 477 BRAZIL: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 478 BRAZIL: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 479 BRAZIL: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 480 MEXICO: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 481 MEXICO: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 482 MEXICO: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 483 MEXICO: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022–2029 (USD MILLION)
  • TABLE 484 MEXICO: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 485 MEXICO: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 486 MEXICO: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 487 MEXICO: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 488 MEXICO: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 489 MEXICO: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 490 MEXICO: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 491 ARGENTINA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 492 ARGENTINA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 493 ARGENTINA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 494 ARGENTINA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022–2029 (USD MILLION)
  • TABLE 495 ARGENTINA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 496 ARGENTINA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 497 ARGENTINA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 498 ARGENTINA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 499 ARGENTINA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 500 ARGENTINA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 501 ARGENTINA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 502 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 503 REST OF LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 504 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 505 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022–2029 (USD MILLION)
  • TABLE 506 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 507 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 508 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 509 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 510 REST OF LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 511 REST OF LATIN AMERICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 512 REST OF LATIN AMERICA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 513 MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 514 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 515 MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 516 MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022–2029 (USD MILLION)
  • TABLE 517 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 518 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 519 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 520 MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 521 MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 522 MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 523 MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 524 MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 525 MIDDLE EAST: KEY MACROECONOMIC INDICATORS
  • TABLE 526 GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 527 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 528 GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 529 GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022–2029 (USD MILLION)
  • TABLE 530 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 531 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 532 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 533 GCC COUNTRIES: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 534 GCC COUNTRIES: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 535 GCC COUNTRIES: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 536 GCC COUNTRIES: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 537 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 538 REST OF MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 539 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 540 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022–2029 (USD MILLION)
  • TABLE 541 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 542 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 543 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 544 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 545 REST OF MIDDLE EAST: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 546 REST OF MIDDLE EAST: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 547 REST OF MIDDLE EAST: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 548 AFRICA: PROTEIN EXPRESSION MARKET, BY OFFERING, 2022–2029 (USD MILLION)
  • TABLE 549 AFRICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 550 AFRICA: PROTEIN EXPRESSION MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)
  • TABLE 551 AFRICA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022–2029 (USD MILLION)
  • TABLE 552 AFRICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 553 AFRICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 554 AFRICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 555 AFRICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 556 AFRICA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 557 AFRICA: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 558 AFRICA: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 559 AFRICA: KEY MACROECONOMIC INDICATORS
  • TABLE 560 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PROTEIN EXPRESSION MARKET, JANUARY 2021–SEPTEMBER 2024
  • TABLE 561 PROTEIN EXPRESSION MARKET: DEGREE OF COMPETITION
  • TABLE 562 PROTEIN EXPRESSION MARKET: REGION FOOTPRINT
  • TABLE 563 PROTEIN EXPRESSION MARKET: OFFERING FOOTPRINT
  • TABLE 564 PROTEIN EXPRESSION MARKET: EXPRESSION SYSTEM FOOTPRINT
  • TABLE 565 PROTEIN EXPRESSION MARKET: APPLICATION FOOTPRINT
  • TABLE 566 PROTEIN EXPRESSION MARKET: DETAILED LIST OF KEY STARTUP/SMES
  • TABLE 567 PROTEIN EXPRESSION MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 568 PROTEIN EXPRESSION MARKET: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 569 PROTEIN EXPRESSION MARKET: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 570 PROTEIN EXPRESSION MARKET: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 571 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 572 THERMO FISHER SCIENTIFIC INC.: PRODUCTS AND SERVICES OFFERED
  • TABLE 573 THERMO FISHER SCIENTIFIC INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 574 THERMO FISHER SCIENTIFIC, INC.: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 575 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 576 MERCK KGAA: COMPANY OVERVIEW
  • TABLE 577 MERCK KGAA: PRODUCTS AND SERVICES OFFERED
  • TABLE 578 MERCK KGAA: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 579 MERCK KGAA: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 580 DANAHER CORPORATION: COMPANY OVERVIEW
  • TABLE 581 DANAHER CORPORATION: PRODUCTS AND SERVICES OFFERED
  • TABLE 582 DANAHER CORPORATION: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 583 DANAHER CORPORATION: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 584 DANAHER CORPORATION: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 585 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
  • TABLE 586 AGILENT TECHNOLOGIES, INC.: PRODUCTS AND SERVICES OFFERED
  • TABLE 587 SARTORIUS AG: COMPANY OVERVIEW
  • TABLE 588 SARTORIUS AG: PRODUCTS AND SERVICES OFFERED
  • TABLE 589 SARTORIUS AG: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 590 SARTORIUS AG: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 591 GENSCRIPT: COMPANY OVERVIEW
  • TABLE 592 GENSCRIPT: PRODUCTS AND SERVICES OFFERED
  • TABLE 593 GENSCRIPT: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 594 TAKARA BIO INC.: COMPANY OVERVIEW
  • TABLE 595 TAKARA BIO INC.: PRODUCTS AND SERVICES OFFERED
  • TABLE 596 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
  • TABLE 597 BIO-RAD LABORATORIES, INC.: PRODUCTS AND SERVICES OFFERED
  • TABLE 598 QIAGEN: COMPANY OVERVIEW
  • TABLE 599 QIAGEN: PRODUCTS AND SERVICES OFFERED
  • TABLE 600 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW
  • TABLE 601 CHARLES RIVER LABORATORIES: PRODUCTS AND SERVICES OFFERED
  • TABLE 602 CORNING INCORPORATED: COMPANY OVERVIEW
  • TABLE 603 CORNING INCORPORATED: PRODUCTS AND SERVICES OFFERED
  • TABLE 604 LONZA: COMPANY OVERVIEW
  • TABLE 605 LONZA: PRODUCTS AND SERVICES OFFERED
  • TABLE 606 LONZA: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 607 LONZA: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 608 FUJIFILM IRVINE SCIENTIFIC, INC.: COMPANY OVERVIEW
  • TABLE 609 FUJIFILM IRVINE SCIENTIFIC, INC.: PRODUCTS AND SERVICES OFFERED
  • TABLE 610 FUJIFILM IRVINE SCIENTIFIC, INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 611 FUJIFILM IRVINE SCIENTIFIC, INC.: DEALS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 612 FUJIFILM IRVINE SCIENTIFIC, INC.: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
  • TABLE 613 SYNGENE INTERNATIONAL LIMITED: COMPANY OVERVIEW
  • TABLE 614 SYNGENE INTERNATIONAL LIMITED: PRODUCTS AND SERVICES OFFERED
  • TABLE 615 SYNGENE INTERNATIONAL LIMITED: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–SEPTEMBER 2024
  • TABLE 616 LGC LIMITED: COMPANY OVERVIEW
  • TABLE 617 LGC LIMITED: PRODUCTS AND SERVICES OFFERED
  • TABLE 618 EUROFINS SCIENTIFIC: COMPANY OVERVIEW
  • TABLE 619 EUROFINS SCIENTIFIC: PRODUCTS AND SERVICES OFFERED
  • TABLE 620 AJINOMOTO CO., INC.: COMPANY OVERVIEW
  • TABLE 621 AJINOMOTO CO., INC.: PRODUCTS AND SERVICES OFFERED
  • TABLE 622 PROMEGA CORPORATION: COMPANY OVERVIEW
  • TABLE 623 SINO BIOLOGICAL, INC.: COMPANY OVERVIEW
  • TABLE 624 RAYBIOTECH, INC.: COMPANY OVERVIEW
  • TABLE 625 BIONEER CORPORATION: COMPANY OVERVIEW
  • TABLE 626 ORIGENE TECHNOLOGIES, INC.: COMPANY OVERVIEW
  • TABLE 627 NEW ENGLAND BIOLABS: COMPANY OVERVIEW
  • TABLE 628 ACCURUS BIOSCIENCES: COMPANY OVERVIEW
  • TABLE 629 ARAGEN LIFE SCIENCES LTD.: COMPANY OVERVIEW
  • TABLE 630 OXFORD EXPRESSION TECHNOLOGIES LTD: COMPANY OVERVIEW
  • TABLE 631 PROTEOGENIX INC.: COMPANY OVERVIEW
  • TABLE 632 ABEOMICS: COMPANY OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 PROTEIN EXPRESSION MARKET SEGMENTATION AND REGIONAL SCOPE
  • FIGURE 2 PROTEIN EXPRESSION MARKET: RESEARCH DESIGN
  • FIGURE 3 PROTEIN EXPRESSION MARKET: BREAKDOWN OF PRIMARY INTERVIEWS
  • FIGURE 4 PROTEIN EXPRESSION MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
  • FIGURE 5 GLOBAL MARKET SIZE ESTIMATION FOR OFFERINGS: COMPANY REVENUE ANALYSIS-BASED ESTIMATION, 2023
  • FIGURE 6 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS, 2023
  • FIGURE 7 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
  • FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 9 PROTEIN EXPRESSION MARKET: CAGR PROJECTIONS
  • FIGURE 10 DATA TRIANGULATION METHODOLOGY
  • FIGURE 11 PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 12 PROTEIN EXPRESSION MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 PROTEIN EXPRESSION MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 PROTEIN EXPRESSION PRODUCTS MARKET, BY PRODUCT TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 16 PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 17 GEOGRAPHICAL SNAPSHOT OF PROTEIN EXPRESSION MARKET
  • FIGURE 18 INCREASING DEMAND FOR PROTEIN BIOLOGICS TO DRIVE MARKET
  • FIGURE 19 US AND PRODUCTS SEGMENT DOMINATED NORTH AMERICAN PROTEIN EXPRESSION MARKET IN 2023
  • FIGURE 20 MAMMALIAN CELL EXPRESSION SYSTEM TO LEAD MARKET DURING FORECAST PERIOD
  • FIGURE 21 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT ACCOUNTED FOR LARGEST SHARE IN 2023
  • FIGURE 22 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT REGISTERED HIGHEST MARKET SHARE IN 2023
  • FIGURE 23 CHINA TO HAVE HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 24 PROTEIN EXPRESSION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 25 APPROVED DRUGS AND BIOLOGICS IN US, 2014–2024
  • FIGURE 26 APPROVED DRUG TYPE IN US, 2023
  • FIGURE 27 APPROVED PERSONALIZED MEDICINES IN US, 2014–2023
  • FIGURE 28 REVENUE SHIFT AND NEW POCKETS FOR PLAYERS IN PROTEIN EXPRESSION MARKET
  • FIGURE 29 AVERAGE SELLING PRICE TREND OF PROTEIN EXPRESSION PRODUCTS, 2021–2023
  • FIGURE 30 AVERAGE SELLING PRICE OF SYSTEM TYPES, BY KEY PLAYER, 2023
  • FIGURE 31 AVERAGE SELLING PRICE TREND OF PROTEIN EXPRESSION INSTRUMENTS, BY KEY PLAYER, 2021–2023
  • FIGURE 32 AVERAGE SELLING PRICE OF PROTEIN EXPRESSION CONSUMABLE PRODUCTS, BY REGION, 2023
  • FIGURE 33 AVERAGE SELLING PRICE TREND OF PROTEIN EXPRESSION INSTRUMENTS, BY REGION, 2021–2023
  • FIGURE 34 PROTEIN EXPRESSION MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 35 PROTEIN EXPRESSION PRODUCTS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 36 PROTEIN EXPRESSION SERVICES MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 37 PROTEIN EXPRESSION MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 38 TYPES OF EXPRESSION SYSTEMS
  • FIGURE 39 METHODS OF PROTEIN EXTRACTION
  • FIGURE 40 PROTEIN EXPRESSION MARKET: PATENT ANALYSIS, JANUARY 2014–SEPTEMBER 2024
  • FIGURE 41 PROTEIN EXPRESSION MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 42 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
  • FIGURE 43 KEY BUYING CRITERIA FOR PROTEIN EXPRESSION PRODUCTS, BY END USER
  • FIGURE 44 KEY BUYING CRITERIA FOR PROTEIN EXPRESSION SERVICES, BY END USER
  • FIGURE 45 NORTH AMERICA: PROTEIN EXPRESSION MARKET SNAPSHOT
  • FIGURE 46 ASIA PACIFIC: PROTEIN EXPRESSION MARKET SNAPSHOT
  • FIGURE 47 REVENUE ANALYSIS OF KEY PLAYERS, 2021–2023 (USD MILLION)
  • FIGURE 48 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2023
  • FIGURE 49 PROTEIN EXPRESSION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 50 PROTEIN EXPRESSION MARKET: COMPANY FOOTPRINT
  • FIGURE 51 PROTEIN EXPRESSION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 52 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2024
  • FIGURE 53 EV/EBITDA OF KEY VENDORS, 2024
  • FIGURE 54 PROTEIN EXPRESSION MARKET: BRAND/PRODUCT COMPARISON
  • FIGURE 55 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 56 MERCK KGAA: COMPANY SNAPSHOT (2023)
  • FIGURE 57 DANAHER CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 58 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 59 SARTORIUS AG: COMPANY SNAPSHOT (2023)
  • FIGURE 60 GENSCRIPT: COMPANY SNAPSHOT (2023)
  • FIGURE 61 TAKARA BIO INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 62 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 63 QIAGEN: COMPANY SNAPSHOT (2023)
  • FIGURE 64 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2023)
  • FIGURE 65 CORNING INCORPORATED: COMPANY SNAPSHOT (2023)
  • FIGURE 66 LONZA: COMPANY SNAPSHOT (2023)
  • FIGURE 67 FUJIFILM IRVINE SCIENTIFIC, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 68 SYNGENE INTERNATIONAL LIMITED: COMPANY SNAPSHOT (2023)
  • FIGURE 69 LGC LIMITED: COMPANY SNAPSHOT (2023)
  • FIGURE 70 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2023)
  • FIGURE 71 AJINOMOTO CO., INC.: COMPANY SNAPSHOT (2023)

This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global protein expression market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

The market for the companies offering protein expression solutions is arrived at by secondary data available through paid and unpaid sources, analyzing the product portfolios of the major companies in the ecosystem, and rating the companies by their performance and quality. Various sources were referred to in the secondary research process to identify and collect information for this study. The secondary sources include annual reports, press releases, investor presentations of companies, white papers, journals, certified publications, and articles from recognized authors, directories, and databases. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and technology-oriented perspectives. Secondary data was analyzed to arrive at the overall size of the global protein expression market, which was validated through primary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global protein expression market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as personnel from pharmaceutical and biopharmaceutical industries, CDMOs and CROs, academic and research institutes, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were conducted across major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World (including Latin America, the Middle East, and Africa). Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

In the complete market engineering process, the top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

The following is a breakdown of the primary respondents:

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The global size of the protein expression market was estimated and validated through multiple approaches such as the top-down and bottom-up approaches. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and market have been identified through extensive primary and secondary research.
  • The revenues generated from the protein expression business of leading players have been determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Data Triangulation

After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable.

Market Definition

The protein expression market encompasses the technologies, products, and services required for the production and analysis of recombinant proteins. This market includes various expression systems (mammalian, bacterial, yeast, algal, insect, and cell-free), reagents and instruments for transfection and cloning, growth reagents for cell culture during translation, and reagents and kits for downstream processes like purification and characterization. It serves industries like pharmaceuticals, biotechnology, academic research institutes, CROs & CDMOs, and other industrial users, supporting applications in drug discovery, therapeutic development, and biochemical research, as well as supporting other industries such as food and beverages, cosmetics, and textile among others.

Stakeholders

  • Biopharmaceutical Companies
  • Contract Research Organizations (CROs)
  • Contract Manufacturing Organizations (CMOs)
  • Biotechnology Companies
  • Academic and Research Institutions
  • Clinical Research Laboratories
  • Pharmaceutical Companies
  • Diagnostic Companies
  • Food & Beverage Companies
  • Suppliers of Expression Systems
  • Protein Expression Instrument & Reagent Manufacturers
  • Regulatory Agencies

Report Objectives

  • To define, describe, and forecast the protein expression market based on system type, offerings, workflow, application, product end user, service end user, and region
  • To provide detailed information regarding the major factors influencing the market growth, such as drivers, restraints, opportunities, and challenges
  • To strategically analyze the micromarkets1 with respect to individual growth trends, future prospects, and contributions to the overall protein expression market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To analyze subsegments of the market with respect to individual growth trends, prospects, and contributions to the overall market
  • To forecast the revenue of the market segments with respect to six main regions, namely, North America (US and Canada), Europe (Germany, UK, France, Italy, Spain, Netherlands, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Africa and the Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina and Rest of Latin America, the Middle East (GCC countries and rest of the Middle East) and Africa.
  • To profile the key market players and comprehensively analyze their market shares and core competencies2
  • To track and analyze competitive developments such as product launches, agreements, partnerships, acquisitions, business expansions, and research & development activities in the protein expression market

Previous Versions of this Report

Protein Expression Market by Type (E.Coli, Mammalian, CHO, HEK 293, Insect, Pichia, Cell-free), Products (Reagents, Vectors, Competent Cells, Instruments, Service), Application (Therapeutic, Industrial), End User & Region - Global Forecast to 2027

Report Code BT 2435
Published in Nov, 2024, By MarketsandMarkets™

Protein Expression Market by Type (E.Coli, Mammalian, CHO, HEK 293, Insect, Pichia, Cell-free), Products (Reagents, Vectors, Competent Cells, Instruments, Service), Application (Therapeutic, Industrial), End User, and Region - Global Forecast to 2027

Report Code BT 2435
Published in Oct, 2022, By MarketsandMarkets™

Protein Expression Market by Type (Escherichia Coli, Mammalian, Yeast, Pichia, Insect, Baculovirus and Cell-free), Products (Reagents, Competent Cells, Instruments, Services), Application, End-User and Region - Global Forecast to 2025

Report Code BT 2435
Published in May, 2020, By MarketsandMarkets™

Protein Expression Market by Type (E. Coli, Mammalian, Yeast, Pichia, Insect, Baculovirus, Cell-free), Products (Competent Cells, Reagents, Instruments, Services), Application (Therapeutic, Research, Industrial) & End User - Global Forecast to 2022

Report Code BT 2435
Published in Jul, 2017, By MarketsandMarkets™

Protein Expression Market by Products (Expression Vector, Service, Reagent), Application (Industrial, Therapeutic), Expression Systems (Mammalian, Prokaryotic, Baculovirus, Yeast) & by End User (Pharmaceutical, Biotechnology, CRO) - Global Forecast to 2018

Report Code BT 2435
Published in Apr, 2014, By MarketsandMarkets™

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Protein Expression Market

DMCA.com Protection Status